This is an oral medication in capsule form.
Gilenya® is a new class of medication called a sphingosine 1-phosphate receptor modulator, which is thought to act by retaining certain white blood cells (lymphocytes) in the lymph nodes, thereby preventing those cells from crossing the blood-brain barrier into the central nervous system (CNS). Preventing the entry of these cells into the CNS reduces inflammatory damage to nerve cells.
Gilenya was approved by the U.S. Food and Drug Administration (FDA) in 2010 for adults with relapsing forms of MS to reduce the frequency of clinical relapses and to delay the accumulation of physical disability.
Click here to read the Gilenya Prescribing Information for healthcare professionals.
Click here to read the Gilenya Medication Guide for patients.
Gilenya Go Program 1-800-GILENYA (1-800-445-3692
Financial Assistance Program
Patient Assistance NOW, www.patientassistancenow.com or call